Dover Pharmaceuticals Private Limited

Manufacturer of pharmaceuticals, healthcare products, and medicinal preparations, including drugs, vaccines, and dietary supplements.

2015 | Bengaluru, Karnataka (India) | Active
Last Updated:

Dover Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.00 Cr
  • Revenue Growth %
  • Profit Growth -26.56%
  • Ebitda -26.56%
  • Net Worth -56.06%
  • Total Assets -6.35%

About Dover Pharmaceuticals

Dover Pharmaceuticals Private Limited (DPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 October 2015 (Nine years and four months 15 days old ). Its registered office is in Bengaluru, Karnataka.

The Company is engaged in the Energy And Power Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹20.00 Cr.

Sabah Kamal, Sara Kamal, and Sanah Kamal serve as directors at the Company.

Company Details

  • Location Bengaluru, Karnataka
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U40100KA2015PTC083584

  • Company No.

    083584

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Oct 2015

  • Date of AGM

    13 Aug 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Energy and Power

Who are the key members and board of directors at Dover Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Sabah Kamal Country flag representing In Director 24-Aug-2022Current
Sara Kamal Country flag representing In Director 30-Jul-2018Current
Sanah Kamal Country flag representing In Director 24-Aug-2022Current

Financial Performance of Dover Pharmaceuticals.

Dover Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 26.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 56.06%.

Dover Pharmaceuticals revenue growth over time
Dover Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-6.35%
Profit or Loss
-26.56%
Net Worth
-56.06%
EBITDA
-26.56%

What is the Ownership and Shareholding Structure of Dover Pharmaceuticals?

In 2022, Dover Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹200.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 20.00 Cr

Latest Charge Details

DateLenderAmountStatus
31 Aug 2024Others₹20.00 CrOpen

How Many Employees Work at Dover Pharmaceuticals?

Unlock and access historical data on people associated with Dover Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Dover Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dover Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dover Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dover Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge with Others amounted to Rs. 200.00 M with Charge ID 100984780 was registered on 31 Aug 2024.

  • Annual General Meeting

    Dover Pharmaceuticals Private Limited last Annual general meeting of members was held on 13 Aug 2024 as per latest MCA records.

  • Balance Sheet

    Dover Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

  • Director Appointment

    Sabah Kamal was appointed as a Director was appointed as a Director on 24 Aug 2022 & has been associated with this company since 2 years 6 months .

  • Director Appointment

    Sanah Kamal was appointed as a Director was appointed as a Director on 24 Aug 2022 & has been associated with this company since 2 years 6 months .

  • Director Appointment

    Sara Kamal was appointed as a Director was appointed as a Director on 30 Jul 2018 & has been associated with this company since 6 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Dover Pharmaceuticals Private Limited?

    Dover Pharmaceuticals Private Limited was incorporated on 21 Oct 2015.

  • What is authorized share capital and paid-up capital of Dover Pharmaceuticals Private Limited?

    The authorized share capital of Dover Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Dover Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Dover Pharmaceuticals Private Limited.

    • Sabah Kamal
    • Sara Kamal
    • Sanah Kamal

  • What is the registered address of Dover Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Dover Pharmaceuticals Private Limited is No. 324 Golden Point 4 1St Floor Off Queens Road Cross Vasant H Nagar, India, Bengaluru, Karnataka, 560052.

  • What is the corporate identification number (CIN) and company number of Dover Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Dover Pharmaceuticals Private Limited is U40100KA2015PTC083584 and the company number is 083584 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Dover Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Dover Pharmaceuticals Private Limited has experienced an downturn of -56.06%.

  • What are the total open charges for Dover Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Dover Pharmaceuticals Private Limited amount to ₹ 20.00 Cr.

  • When was the last Balance Sheet of Dover Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Dover Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Power Transmission & Distribution Services